本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enliven Treateutics

61.15
+1.332.22%
盤前61.14-0.0100-0.02%06:02 EDT
成交量:125.52萬
成交額:7,612.09萬
市值:44.81億
市盈率:-36.50
高:61.99
開:59.77
低:59.47
收:59.82
52周最高:62.32
52周最低:14.79
股本:7,327.08萬
流通股本:6,172.59萬
量比:1.73
換手率:2.03%
股息:- -
股息率:- -
每股收益(TTM):-1.6753
每股收益(LYR):-1.8300
淨資產收益率:-15.31%
總資產收益率:-11.00%
市淨率:5.01
市盈率(LYR):-33.42

資料載入中...

2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]